Rami Levi's most recent trade in Cns Pharmaceuticals Inc was a trade of 19,000 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cns Pharma Inc | Rami Levin | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 19,000 | 19,000 | - | - | Restricted Stock Units | |
| Pluri Inc | Rami Levi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 653 | 18,967 (0%) | 0% | 0 | Common Stock | |
| Pluri Inc | Rami Levi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 11,173 | 18,314 (0%) | 0% | 0 | Common Stock | |
| Pluri Inc | Rami Levi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 37,100 | 57,100 (0%) | 0% | 0 | Common Stock |